Abstract
Water-soluble polymers have been used in the last two decades to modify the pharmacokinetics and physicochemical properties of targeted therapeutic agents. Non-invasive imaging techniques such as nuclear imaging can be used to assess the drug delivery efficiency of novel formulations in a cost-effective fashion and thereby facilitate their development process. Polymeric radiopharmaceuticals have also been investigated on their own right as potential nuclear imaging agents. Clinical applications of polymeric radiopharmaceuticals include blood-pool imaging and targeted molecular imaging. In the latter case, water-soluble polymers are often used to modify the pharmacokinetics and biodistribution pattern of ligands that target receptors or antigens at disease sites. As advances are continue to be made in the emerging field of molecular imaging, nuclear imaging will play an increasingly important role in the development of polymeric drug delivery systems. Similarly, polymer technology will also be integrated into the development of molecularly targeted radiopharmaceuticals. Here, we review various aspects of polymeric radiotracers and their applications in nuclear imaging.
Keywords: nuclear imaging, water-soluble polymers, poly(l-glutamic acid), polyethylene glycol, drug targeting
Current Drug Delivery
Title: Polymeric Radiotracers in Nuclear Imaging
Volume: 1 Issue: 4
Author(s): Xiaoxia Wen, Xianyi Cao, Marites J. Pasuelo, Richard Wendt and Chun Li
Affiliation:
Keywords: nuclear imaging, water-soluble polymers, poly(l-glutamic acid), polyethylene glycol, drug targeting
Abstract: Water-soluble polymers have been used in the last two decades to modify the pharmacokinetics and physicochemical properties of targeted therapeutic agents. Non-invasive imaging techniques such as nuclear imaging can be used to assess the drug delivery efficiency of novel formulations in a cost-effective fashion and thereby facilitate their development process. Polymeric radiopharmaceuticals have also been investigated on their own right as potential nuclear imaging agents. Clinical applications of polymeric radiopharmaceuticals include blood-pool imaging and targeted molecular imaging. In the latter case, water-soluble polymers are often used to modify the pharmacokinetics and biodistribution pattern of ligands that target receptors or antigens at disease sites. As advances are continue to be made in the emerging field of molecular imaging, nuclear imaging will play an increasingly important role in the development of polymeric drug delivery systems. Similarly, polymer technology will also be integrated into the development of molecularly targeted radiopharmaceuticals. Here, we review various aspects of polymeric radiotracers and their applications in nuclear imaging.
Export Options
About this article
Cite this article as:
Wen Xiaoxia, Cao Xianyi, Pasuelo J. Marites, Wendt Richard and Li Chun, Polymeric Radiotracers in Nuclear Imaging, Current Drug Delivery 2004; 1 (4) . https://dx.doi.org/10.2174/1567201043334533
DOI https://dx.doi.org/10.2174/1567201043334533 |
Print ISSN 1567-2018 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Oxidative Stress in Atherosclerosis Development: The Central Role of LDL and Oxidative Burst
Endocrine, Metabolic & Immune Disorders - Drug Targets Haploinsufficiency of DNA Damage Response Genes and their Potential Influence in Human Genomic Disorders
Current Genomics Initiation of the Immune Response by Extracellular Hsp72: Chaperokine Activity of Hsp72
Current Immunology Reviews (Discontinued) Antipsoriatic Drug Development: Challenges and New Emerging Therapies
Recent Patents on Inflammation & Allergy Drug Discovery Gene and Gene-Environment Risk Factors in Sudden Undexpected Death in Infants
Current Pediatric Reviews Obesity and Pregnancy
Current Women`s Health Reviews Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Inflammation and Coagulation in Urticaria and Angioedema
Current Vascular Pharmacology Perioperative Management of Obese Parturients
Current Women`s Health Reviews Review of Recent Patents on Foldable Ventricular Assist Devices
Recent Patents on Biomedical Engineering (Discontinued) Effect of Simvastatin use on Autonomic Function in Patients with End Stage Renal Disease
Cardiovascular & Hematological Disorders-Drug Targets Nanomedicine against Alzheimer’s and Parkinson’s Disease
Current Pharmaceutical Design Genetic Insights into Sepsis: What have we Learned and How will it Help?
Current Pharmaceutical Design In Vivo, Cardiac-Specific Knockdown of a Target Protein, Malic Enzyme- 1, in Rat via Adenoviral Delivery of DNA for Non-Native miRNA
Current Gene Therapy Endobronchial Ultrasound-guided Transbronchial Needle Aspiration
Reviews on Recent Clinical Trials Brief Messages to Promote Prevention and Detection of Sexually Transmitted Infections
Current HIV Research Scope of Nanotechnology-based Radiation Therapy and Thermotherapy Methods in Cancer Treatment
Current Cancer Drug Targets Pathophysiology of Myocardial Infarction and Acute Management Strategies
Cardiovascular & Hematological Agents in Medicinal Chemistry A Promising Future for Peptides in Ophthalmology: Work Effectively and Smartly
Current Medicinal Chemistry Recent Advances in Biological Strategies for Targeted Drug Delivery
Cardiovascular & Hematological Disorders-Drug Targets